- t2cure’s cell therapy is available through cooperating clinical centres
- t2cure cooperates with experienced partners in research and in the industry.
- t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
- t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.
t2cure’s lead product broadcasted on German TV
On March 7, 2008 a life report was broadcasted on German TV about t2cure’s lead product and t2cure’s collaboration with the university clinics and the blood donor service in Frankfurt.
t2cure on German TV
© 2008 Hessischer Rundfunk